FindTrial
Sign In

Creating a data base registry for patients duffering from Scleroderma from who is under treatment in various hospitals in India

Progressive Systemic Sclerosis registry for participating institutes in India

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023162
Enrollment
1000
Registered
2020-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Center for Arthritis and Rheumatism Excellence
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patient should fulfill the 2013 ACR/EULAR Classification criteria for systemic sclerosis

Exclusion criteria

Exclusion criteria: patient with diagnosed systemic sclerosis who are unwilling to participate in the study

Design outcomes

Primary

MeasureTime frame
create registry for Progressive systemic sclerosis by collating data from 6 participating centersTimepoint: End of study—

Secondary

MeasureTime frame
1. collection of demographic and clinical characteristics in the Indian population 2. determine the time taken to referral and diagnosis 3. correlation of clinical features with antibody positivity 4. the management of scleroderma in various situations 5. collection and storage of samples for biomarkers and other researchTimepoint: End of the study—

Countries

India

Contacts

Public ContactDrPadmanabha Shenoy D

Sree Sudheendra Medical Mission Hospital

drdpshenoy@gmail.com9446567000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026